Showing results (1-10 of 91) with videos related to
Sort By:
Pageof 10
Current Research in Translational Medicine|October 10, 2017
Chimeric antigen-receptor T-cell therapy for hematological malignancies and solid tumors: Clinical data to date, current limitations and perspectivesJ Gauthier, I Yakoub-AghaBone Marrow Transplantation|February 26, 2014
Donor-derived CD4(+)/CCR7(+) T-cell partial selective depletion does not alter acquired anti-infective immunityB Choufi, J Trauet, S Thiant, et al.Current Research in Translational Medicine|June 12, 2019
An international survey on the management of patients receiving CAR T-cell therapy for haematological malignancies on behalf of the Chronic Malignancies Working Party of EBMTP J Hayden, T Sirait, L Koster, et al.Bone Marrow Transplantation|September 3, 2008
Efficacy of imatinib mesylate in the treatment of refractory sclerodermatous chronic GVHDL Magro, B Catteau, V Coiteux, et al.Current Research in Translational Medicine|October 3, 2018
Burden of cytomegalovirus disease in allogeneic hematopoietic cell transplant recipients: a national, matched cohort study in an inpatient settingZ Hakimi, S Ferchichi, S Aballea, et al.Bone Marrow Transplantation|January 11, 2012
Enteral nutrition: a first option for nutritional support of children following allo-SCT?S Azarnoush, B Bruno, L Beghin, et al.Leukemia|October 26, 2011
Treatment strategies in relapsed and refractory multiple myeloma: a focus on drug sequencing and 'retreatment' approaches in the era of novel agentsB Mohty, J El-Cheikh, I Yakoub-Agha, et al.Bone Marrow Transplantation|December 7, 2010
Plasma levels of IL-7 and IL-15 after reduced intensity conditioned allo-SCT and relationship to acute GVHDS Thiant, M Labalette, J Trauet, et al.Bone Marrow Transplantation|January 13, 2004
Donor lymphocyte infusion to treat relapse after allogeneic bone marrow transplantation for myelodysplastic syndromeS Depil, E Deconinck, N Milpied, et al.Pageof 10